BML, Inc. (MUN:BMZ)

Market Cap	773.22M
Revenue (ttm)	859.46M
Net Income (ttm)	37.88M
Shares Out	n/a
EPS (ttm)	0.97
PE Ratio	20.41
Forward PE	n/a
Dividend	0.77 (3.79%)
Ex-Dividend Date	Sep 29, 2025

Volume	n/a
Average Volume	n/a
Open	20.40
Previous Close	20.80
Day's Range	20.20 - 20.40
52-Week Range	16.10 - 21.20
Beta	n/a
RSI	42.59
Earnings Date	Nov 7, 2025

About BML, Inc.

BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from...

• Industry: Commercial Physical and Biological Research
• Founded: 1955
• Employees: 4,558
• Stock Exchange: Munich Stock Exchange
• Ticker Symbol: BMZ

Financial Performance

In 2024, BML, Inc.'s revenue was 143.19 billion, an increase of 3.79% compared to the previous year's 137.96 billion. Earnings were 6.26 billion, an increase of 3.80%.

Financial numbers in JPY